P01: Immune Targeting of Tumor Cells Using Recall of Pre-Existing Microbiota Specific T-Cells, Presented by Jean-Marie C., Enterome

P02: Anti-FLT3 Car-T and Bispecific Antibody Therapies for Effective Elimination of AML and Conditioning for Hematopoietic Stem Cell Transplantation, Presented by Vladislav S., Hemogenyx Pharmaceuticals LLC

P03: Autologous Organoid-T Cell Co-Culture Platform as a Powerful Personalized Model for Immuno-Oncology Therapy, Presented by Soura M., Hubrecht Organoid Technology (HUB)

P04: A blood-miRNA Based Complementary Diagnostic Predicts Immunotherapy Efficacy in Advanced Stage NSCLC with High PD-L1 Expression, Presented by Timothy R., Hummingbird Diagnostics GmbH

P05: Cell Avidity a Crucial Biomarker for Predicting T-Cell Therapeutic Function, Presented by Peter D., LUMICKS BV

P06: Immune Laboratory Status of Cancer Patients Afterward Infections Coronavirus Infection (COVID-19), Presented by Karlygash T., Maastricht University

P07: An Innovative Ex-Vivo Tumoroid Model of Fresh Patient Tumor Tissue to Evaluate the Combination of STING Agonists Alone and in Combination with Nivolumab on Tumor Microenvironment in Colorectal Cancer, Presented by William C., Nilogen Oncosystems

P08: ON203: A New Antibody Targeting the Oxidized Form of Macrophage Migration Inhibitory Factor Demonstrates Antitumorigenic Activity in Preclinical Models, Presented by Michael T., OncoOne Research & Development GmbH

P09: Does Puberty Acquired Infection with Microbiome Anaerobes Explain Link with Prostate Cancer and Offer New Therapeutic Approaches?, Presented by Tim O., Queen Mary University of London

P10: Durable, Multiplexed, Cell Engineering Using Zinc-Finger Guided Transcriptional Regulators Delivered via a Single Viral Particle, Presented by Maud B., Sangamo Therapeutics

P11: Deconvolution of Adult T-Cell Leukemia/Lymphoma With Single-Cell RNA-Seq Using Frozen Archived Skin Tissue Reveals New Subset of Cancer-Associated Fibroblast, Presented by Yoonji B., Seoul National University

P12: Beyond Mutagenesis: UVB Immunomodulation Alters Melanoma Progression in a Site Dependent Manner, Presented by Avishai M., Tel Aviv University

P13: Regulatory T Cells as Determinants of Adaptive and Innate Function in Brain Tumours, Presented by Felipe GC., University College London

P14: Application of a Dual Expression System to Target the Tumour Microenvironment in Drosophila Cancer Models, Presented by Hend A., University of Liverpool

P15: Target-Dependent, T-Cell Activating Bispecific Antibody AP203 (PD-L1 x 4-1BB) for Cancer Therapy, Presented by Jhong-Jhe Y., AP Biosciences, Inc.

P16: Highly Multiplexed, Single-Cell Functional Profiling of CAR-T Products Enables More Predictive Product Characterization, Cell Manufacturing Optimization, and Cellular Biomarkers Across Product Types, Presented by Mourad F., IsoPlexis

Register Now